329 related articles for article (PubMed ID: 32945455)
1. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
2. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model.
Quan Q; Ma X; Li M; Li X; Yuan H
Exp Ther Med; 2024 Jan; 27(1):31. PubMed ID: 38125359
[TBL] [Abstract][Full Text] [Related]
6. Effects of ginsenoside Rg1 on the expression of toll-like receptor 3, 4 and their signalling transduction factors in the NG108-15 murine neuroglial cell line.
Zhao BS; Liu Y; Gao XY; Zhai HQ; Guo JY; Wang XY
Molecules; 2014 Oct; 19(10):16925-36. PubMed ID: 25340298
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells.
Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W
Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone Reduces β Amyloid Levels
Quan Q; Qian Y; Li X; Li M
Front Aging Neurosci; 2019; 11():178. PubMed ID: 31379559
[TBL] [Abstract][Full Text] [Related]
9. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.
Fang F; Chen X; Huang T; Lue LF; Luddy JS; Yan SS
Biochim Biophys Acta; 2012 Feb; 1822(2):286-92. PubMed ID: 22015470
[TBL] [Abstract][Full Text] [Related]
10. Notoginseng Saponin Rg1 Prevents Cognitive Impairment through Modulating APP Processing in Aβ
Liu SZ; Cheng W; Shao JW; Gu YF; Zhu YY; Dong QJ; Bai SY; Wang P; Lin L
Curr Med Sci; 2019 Apr; 39(2):196-203. PubMed ID: 31016510
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt.
Shi C; Zheng DD; Fang L; Wu F; Kwong WH; Xu J
Biochim Biophys Acta; 2012 Apr; 1820(4):453-60. PubMed ID: 22178929
[TBL] [Abstract][Full Text] [Related]
13. Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease.
Sadleir KR; Vassar R
J Biol Chem; 2012 Mar; 287(10):7224-35. PubMed ID: 22223639
[TBL] [Abstract][Full Text] [Related]
14. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPARγ/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury.
Yang Y; Li X; Zhang L; Liu L; Jing G; Cai H
Int J Clin Exp Pathol; 2015; 8(3):2484-94. PubMed ID: 26045754
[TBL] [Abstract][Full Text] [Related]
16. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
17. Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease.
Mu JS; Lin H; Ye JX; Lin M; Cui XP
Mol Med Rep; 2015 Sep; 12(3):3862-3868. PubMed ID: 26016457
[TBL] [Abstract][Full Text] [Related]
18. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein.
Gong L; Li SL; Li H; Zhang L
Pharm Biol; 2011 May; 49(5):501-7. PubMed ID: 21438847
[TBL] [Abstract][Full Text] [Related]
20. Roscovitine, a CDK5 Inhibitor, Alleviates Sevoflurane-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling.
Liu J; Yang J; Xu Y; Guo G; Cai L; Wu H; Zhao Y; Zhang X
Cell Physiol Biochem; 2017; 44(2):423-435. PubMed ID: 29141245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
